Weekly GA Feedback for Sustainable Blood Glucose Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Diabetes management is challenging due to the difficulty in maintaining long-term lifestyle changes and behavioral motivation, with existing biomarkers like fasting blood glucose and HbA1c providing insufficient feedback for effective glycemic management.

Innovation Solution

A computer system utilizing GA values to assist users in setting and tracking weekly lifestyle goals, providing real-time feedback and guidance for glycemic management through a user interface, including goal setting, GA value monitoring, and behavioral input.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If HbA1c is used as a biomarker for glycemic control, then it reflects blood glucose levels over the past two to three months, but it is too long as feedback for behavioral change and difficult to maintain motivation

Engineering Contradiction:
Improvefeedback timelinessVSAvoidfeedback period
Core Design Contradiction:
Measurement precisionVSDuration of action of moving object

Solution Approach 1:

The patent segments the feedback period into two distinct components: GA value feedback for short-term behavioral monitoring (1-3 weeks) and HbA1c for long-term glycemic control assessment (2-3 months). This segmentation allows users to receive timely feedback for motivation while maintaining comprehensive long-term monitoring.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces GA value as an intermediary biomarker that bridges the gap between frequent self-monitoring needs and the longer HbA1c measurement cycle. GA value provides intermediate feedback that is timely enough to motivate behavioral changes while still reflecting meaningful glycemic trends.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Speed

If fasting blood glucose levels are used as a biomarker, then they can be measured frequently, but they can hardly be considered to reflect lifestyle

Engineering Contradiction:
Improvemeasurement frequencyVSAvoidlifestyle reflection capability
Core Design Contradiction:
SpeedVSLoss of information

Solution Approach 1:

The patent merges multiple biomarkers (GA value, HbA1c, and fasting blood glucose) into a comprehensive glycemic management system. Each biomarker contributes different information: fasting blood glucose provides immediate metabolic status, GA value reflects recent lifestyle patterns (1-3 weeks), and HbA1c shows long-term trends (2-3 months), together providing a complete picture.

Inventive Principle:
Principle #5Merging (Combining)

3Reliability

If lifestyle improvement is required for glycemic management, then complete cure is difficult and treatment must be continued for a lifetime, but this makes self-management difficult to maintain

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidself-management sustainability
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent implements a multi-level feedback system with weekly GA value monitoring providing short-term motivation, monthly HbA1c testing providing long-term validation, and daily fasting blood glucose monitoring providing immediate metabolic feedback. This layered feedback structure sustains self-management motivation over the lifetime required for chronic disease management.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent establishes periodic measurement cycles: weekly GA value assessments for behavioral feedback, monthly or quarterly HbA1c testing for long-term control verification, and daily fasting blood glucose monitoring for immediate lifestyle adjustments. These periodic actions create rhythm and structure that sustain long-term self-management.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentEP4712092A1Method for assisting blood glucose control of subject by using computer system, and computer system
Publication Date: 2026.03.18 PROVIGATE KK
  • EP4712092A1 patent drawingFigure A1
  • EP4712092A1 patent drawingFigure BB1
  • EP4712092A1 patent drawingFigure A2

AI summary

According to an embodiment of the present disclosure, there is provided a method for assisting glycemic control of a subject using a computer system, the method including acquiring a self-set goal of the subject; acquiring GA values of the subject; generating a GA value trend using a plurality of the GA values; outputting the GA value trend to the subject; and outputting the self-set goal of the subject to the subject.